AKTX Stock Analysis: Buy, Sell, or Hold?
AKTX - Akari Therapeutics plc ADR (0.01 USD)
$8.77
0.64 (7.87%)
▲
5d:
+0.57%
30d:
-19.39%
90d:
-34.55%
WAIT
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When AKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AKTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AKTX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AKTX is currently trading at $8.77, which is considered oversold relative to its 30-day fair value range of $8.90 to $10.71.
Technical Outlook: Technically, AKTX is in a downtrend. Immediate support is located at $8.05, while resistance sits at $10.97. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $25.50 (+190.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKTX is in a downtrend. Immediate support is located at $8.05, while resistance sits at $10.97. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $25.50 (+190.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.90 -
$10.71
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.9%)
- BULLISH: Trading 190.8% below Wall St target ($25.50)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.90 -
$10.71
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.05
Resistance Level
$10.98
Current Trend
Downtrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.01
Wall Street Target
$25.50
(+190.8%)
Share & Embed Analysis
Last updated: October 11, 2026 4:07 PM ET
Data refreshes hourly during market hours. Next update: 5:07 PM
Data refreshes hourly during market hours. Next update: 5:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$198 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$110 | 67 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 70 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$682 | 43 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 57 HOLD |
